This story has been updated to include comments from Bio-Rad Laboratories and to explain the remedies available in USITC patent cases.
NEW YORK – The US International Trade Commission has upheld a judge's previous determination that certain microfluidic products imported by Bio-Rad Laboratories indirectly infringe patents held by 10x Genomics.